Future Neurology logo Future Medicine logo

Future Neurology provides a forum to address the most important challenges and advances in our understanding of neurological disease, and highlights emerging trends and prospects for effective treatments in common but very serious disorders such as stroke, epilepsy, multiple sclerosis and Parkinson's disease.

Publisher: Future Medicine

Volume 2, Number 4, July 2007
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

< previous issue | next issue > | all issues

Editorial

New neuroprotective approaches for stroke: use of decoy peptides targeting specific molecular events
pp. 343-346(4)
Author: Baudry, Michel

From the EGR gene family to common pathways in schizophrenia: single genes versus convergent pathways
pp. 347-351(5)
Authors: Yamada, Kazuo; Yoshikawa, Takeo

Pharmacogenomics of Alzheimer's disease and cerebral palsy: implications of the apolipoprotein E genotype
pp. 353-356(4)
Author: Wainwright, Mark S

Bulletin Board

Identification of GAB2 as a risk factor for late-onset Alzheimer's disease
pp. 357-359(3)

Drug Evaluation

Efficacy and safety of desvenlafaxine succinate in the treatment of major depressive disorder
pp. 361-371(11)
Authors: Kamath, Jayesh; DeMartinis, Nicholas; Handratta, Venkatesh

Clinical Trial Report

BOLDER II study of quetiapine therapy for bipolar depression
pp. 373-377(5)
Author: Thase, Michael E

The BRAINz trial: a novel approach to acetylcholinesterase-inhibitor treatment for Alzheimer's disease
pp. 379-382(4)
Authors: Wilkinson, David; Roughan, Laura

Priority Paper Evaluation

Cell specificity of altered cation-chloride cotransporter expression and GABAergic innervation in the epileptic cerebral cortex
pp. 383-387(5)
Authors: Muñoz, Alberto; DeFelipe, Javier

Perspective

Towards individualized medicine: flies lead the way
pp. 389-396(8)
Authors: Elliott, Jamie L; Yin, Jerry CP

Review

Molecular determinants of Alzheimer's disease Aβ peptide neurotoxicity
pp. 397-409(13)
Authors: Cappai, Roberto; Barnham, Kevin J

Multifunctional neuroprotective-neurorescue drugs for Parkinson's disease
pp. 411-423(13)
Authors: Van der Schyf, Cornelis J; Geldenhuys, Werner J; Youdim, Moussa BH

Antiapoptotic therapies in the treatment of spinal cord injury
pp. 425-434(10)
Authors: Cittelly, Diana M; Perez-Polo, J Regino

Effect on gene expression of therapeutic hypothermia in cerebral ischemia
pp. 435-440(6)
Authors: Han, Hyung Soo; Yenari, Midori A

Bipolar disorder pharmacotherapy
pp. 441-450(10)
Authors: Denko, Timothey C; Thase, Michael E

Post-polio syndrome: clinical manifestations and cerebrospinal fluid markers
pp. 451-463(13)
Authors: Fiorini, Michele; Zanusso, Gianluigi; Baj, Andreina; Bertolasi, Laura; Toniolo, Antonio; Monaco, Salvatore

< previous issue | next issue > | all issues

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A